Cargando…
Yellow Fever Virus Vaccine–associated Deaths in Young Women
Yellow fever vaccine–associated viscerotropic disease is a rare sequela of live-attenuated virus vaccine. Elderly persons and persons who have had thymectomies have increased susceptibility. A review of published and other data suggested a higher than expected number of deaths from yellow fever vacc...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310656/ https://www.ncbi.nlm.nih.gov/pubmed/22000363 http://dx.doi.org/10.3201/eid1710.101789 |
_version_ | 1782227678607179776 |
---|---|
author | Seligman, Stephen J. |
author_facet | Seligman, Stephen J. |
author_sort | Seligman, Stephen J. |
collection | PubMed |
description | Yellow fever vaccine–associated viscerotropic disease is a rare sequela of live-attenuated virus vaccine. Elderly persons and persons who have had thymectomies have increased susceptibility. A review of published and other data suggested a higher than expected number of deaths from yellow fever vaccine–associated viscerotropic disease among women 19–34 years of age without known immunodeficiency. |
format | Online Article Text |
id | pubmed-3310656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-33106562012-06-27 Yellow Fever Virus Vaccine–associated Deaths in Young Women Seligman, Stephen J. Emerg Infect Dis Dispatch Yellow fever vaccine–associated viscerotropic disease is a rare sequela of live-attenuated virus vaccine. Elderly persons and persons who have had thymectomies have increased susceptibility. A review of published and other data suggested a higher than expected number of deaths from yellow fever vaccine–associated viscerotropic disease among women 19–34 years of age without known immunodeficiency. Centers for Disease Control and Prevention 2011-10 /pmc/articles/PMC3310656/ /pubmed/22000363 http://dx.doi.org/10.3201/eid1710.101789 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Dispatch Seligman, Stephen J. Yellow Fever Virus Vaccine–associated Deaths in Young Women |
title | Yellow Fever Virus Vaccine–associated Deaths in Young Women |
title_full | Yellow Fever Virus Vaccine–associated Deaths in Young Women |
title_fullStr | Yellow Fever Virus Vaccine–associated Deaths in Young Women |
title_full_unstemmed | Yellow Fever Virus Vaccine–associated Deaths in Young Women |
title_short | Yellow Fever Virus Vaccine–associated Deaths in Young Women |
title_sort | yellow fever virus vaccine–associated deaths in young women |
topic | Dispatch |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310656/ https://www.ncbi.nlm.nih.gov/pubmed/22000363 http://dx.doi.org/10.3201/eid1710.101789 |
work_keys_str_mv | AT seligmanstephenj yellowfevervirusvaccineassociateddeathsinyoungwomen |